Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about boron technology
Pipeline

Utilizing our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

 
Pipeline Graphic
 
 
New Releases

Monday, July 21, 2014 | Anacor Pharmaceuticals and Sandoz Enter Into an Agreement for the Commercialization of KERYDIN in the United States
Tuesday, July 8, 2014 | FDA Approves Anacor Pharmaceuticals' KERYDIN™ (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails
Friday, May 30, 2014 | Anacor Pharmaceuticals Appoints Keith R. Leonard, Jr. to Board of Directors
 
New Releases Graphic